In order to further the goals of the MSKCC-Cornell Center for Translation of Cancer Nanomedicines (MC2TCN) the Developmental Program (DP) of the Center will identify two times three Pilot Projects (PPs) in two subsequent funding cycles over the fife-year lifetime of the Center, two funded by the Center grant, and one by using funds from the MSKCC institutional commitment, in order to achieve the following objectives: (i) to address and lower barriers that currently exist between the scientific/engineering and clinical communities in order to accelerate translation of nanotechnological probes to clinical applications in oncology; (ii) to focus the attention of the community to the biggest hurdles to translation of nanomaterials to the clinic including determination of biodistribution of nanomaterials as well as the development of imaging modalities for visualizing the biodistribution over time; and (iii) to enable the support of primarily junior faculty members. A DP Committee consisting of MC2TCN project and core leaders will generate a ?Request for Applications? (RFA) to solicit proposals and appoint a review committee, which will include members of the MC2TCN External Advisory Panel (EAP). PPs will be selected according to well-defined guidelines and will be reviewed biannually.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Specialized Center--Cooperative Agreements (U54)
Project #
Application #
Study Section
Special Emphasis Panel (ZCA1-TCRB-Q (M1))
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Sloan-Kettering Institute for Cancer Research
New York
United States
Zip Code
GrĂ¼ner, Florian; Blumendorf, Florian; Schmutzler, Oliver et al. (2018) Localising functionalised gold-nanoparticles in murine spinal cords by X-ray fluorescence imaging and background-reduction through spatial filtering for human-sized objects. Sci Rep 8:16561
Chen, Feng; Ma, Kai; Madajewski, Brian et al. (2018) Ultrasmall targeted nanoparticles with engineered antibody fragments for imaging detection of HER2-overexpressing breast cancer. Nat Commun 9:4141
Nath, Pooja; Mangal, Rahul; Kohle, Ferdinand et al. (2018) Dynamics of Nanoparticles in Entangled Polymer Solutions. Langmuir 34:241-249
Chen, Feng; Zhang, Xiuli; Ma, Kai et al. (2018) Melanocortin-1 Receptor-Targeting Ultrasmall Silica Nanoparticles for Dual-Modality Human Melanoma Imaging. ACS Appl Mater Interfaces 10:4379-4393
Ma, Kai; Gong, Yunye; Aubert, Tangi et al. (2018) Self-assembly of highly symmetrical, ultrasmall inorganic cages directed by surfactant micelles. Nature 558:577-580
He, Frank; Chiou, Aaron E; Loh, Hyun Chae et al. (2017) Multiscale characterization of the mineral phase at skeletal sites of breast cancer metastasis. Proc Natl Acad Sci U S A 114:10542-10547
Chen, Feng; Ma, Kai; Benezra, Miriam et al. (2017) Cancer-Targeting Ultrasmall Silica Nanoparticles for Clinical Translation: Physicochemical Structure and Biological Property Correlations. Chem Mater 29:8766-8779
Chen, Feng; Ma, Kai; Zhang, Li et al. (2017) Target-or-Clear Zirconium-89 Labeled Silica Nanoparticles for Enhanced Cancer-Directed Uptake in Melanoma: A Comparison of Radiolabeling Strategies. Chem Mater 29:8269-8281
Yoo, B; Ma, K; Wiesner, U et al. (2017) Expanding Analytical Tools for Characterizing Ultrasmall Silica-based Nanoparticles. RSC Adv 7:16861-16865
Bradbury, Michelle S; Pauliah, Mohan; Zanzonico, Pat et al. (2016) Intraoperative mapping of sentinel lymph node metastases using a clinically translated ultrasmall silica nanoparticle. Wiley Interdiscip Rev Nanomed Nanobiotechnol 8:535-53

Showing the most recent 10 out of 12 publications